SightLife began its service to Northern California, helping even more people to see
In 2006, SightLife began service to Northern California, helping more people to see. SightLife formerly known as Sight…
NCI and NHGRI launched effort to accelerate understanding molecular basis of cancer with genome analysis
On Dec. 13, 2005, the National Cancer Institute and the National Human Genome Research Institute launched a comprehensive…
Studies validated a new test can predict risk of breast cancer recurrence in a sizable group of patients
On Dec. 7, 2005, results from several studies presented at the San Antonio Breast Cancer Symposium validated that…
Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively for cancer patients
On Dec. 1, 2005, the Barbara Ann Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively…
Preliminary results from the Digital vs Film Mammographic Imaging Screening Trial showed no difference in breast cancer detection
On Oct. 27, 2005, preliminary results from the Digital vs. Film Mammographic Imaging Screening Trial showed no difference…
FDA approved lowering the age limit to 12 mos for remaining US-licensed hepatitis A vaccine in the US
On Oct. 17, 2005, the FDA approved lowering the age limit to 12 mos for the remaining U.S.-licensed…
The National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer initiative
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
The genome of the 1918 H1N1 pandemic influenza virus was sequenced
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
NCI and NINDS created Rembrandt (Repository for Molecular Brain Neoplasia Data)
On Sept. 28, 2005, the National Cancer Institute and the National Institute of Neurological Disorders and Stroke (NINDS)…
The Worm Institute for Research and Medicine was established at the Scripps Research Institute
On Sept. 26, 2005, San Diego business leader and philanthropist John J. Moores contributed $4 million to The…
Preliminary results from clinical trial of digital vs film mammography showed no difference in breast cancer detection
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
An inactivated, injectable influenza vaccine was licensed
On Aug. 31, 2005, the inactivated, injectable influenza vaccine (Fluarix by GlaxoSmithKline) was licensed. The vaccine was indicated…
The Medically Fragile Children’s Program was established at the Medical University of South Carolina
On Aug. 18, 2005, the Medically Fragile Children’s Program was established at the Medical University of South Carolina….
The Priestley Medal was awarded to Paul S Anderson
On Jun. 13, 2005, The Priestley Medal was awarded to Paul S. Anderson by the American Chemical Society…
The National Cancer Institute announced the Community Networks Program
On May 6, 2005, the National Cancer Institute announced the Community Networks Program (CNP), a 5-year initiative to…
Cellular pertussis vaccine combined with adult formulation of tetanus and diphtheria licensed in persons 10-18 years of age
On May 3, 2005, the cellular pertussis vaccine combined with the adult formulation of tetanus and diphtheria (Tdap:…
Karmanos Cancer Institute acquired clinical facilities from the Detroit Medical Center
On May 1, 2005, The Wayne State University Karmanos Cancer Institute announced it had acquired its clinical facilities…
Amylin Pharmaceuticals and Eli Lilly annnounced Byettaï¾® approved and launched in the US
On Apr. 29, 2005, Amylin Pharmaceuticals and Eli Lilly announced the FDA had approved BYETTA(TM) (exenatide) injection as…
NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence
On Apr. 27, 2005, results from two large NCI-sponsored randomized clinical trials showed that patients with early-stage, HER2-positive,…
NCI trial reported targeted agent trastuzumab and standard chemo cut risk of HER-2-positive breast cancer
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 15, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
The Nebraska Biocontainment Unit was established at UNMC
On Mar. 7, 2005, the CDC commissioned the Nebraska Biocontainment Unit at UNMC. The funding came from federal…
The National Cancer Institute and FDA established an NCI-FDA Research and Regulatory Review Fellowship program
On Feb. 16, 2005, in preparation for the new generation of molecular-based oncology medical products, the National Cancer…
Formation of the Drug Safety Board was announced
On Feb. 16, 2005, Formation of the Drug Safety Board was announced, consisting of FDA staff and representatives…
Smallpox appeared in the first agricultural settlements in northeastern Africa
On Jan. 8, 2005, researchers from Baylor University Medical Center reported that although the origin of smallpox is…
The Institute for Translational Medicine and Therapeutics (ITMAT) was established
In Jan. 2005, the Institute for Translational Medicine and Therapeutics (ITMAT) was established at Penn’s Perelman School of…
FDA approved albumin-stabilized nanoparticle formulation of paclitaxel for treatment of breast cancer
In Jan. 2005, the U.S. Food and Drug Administration approved an albumin-stabilized nanoparticle formulation of paclitaxel (Abraxane) for…
The Patient Navigator Research Program assessed impact of patient navigators
In 2005, The Patient Navigator Research Program (PNRP), a National Cancer Institute initiative, was underway to assess the…
HHS Pandemic Influenza Plan was published
In 2005 and 2006, the White House Homeland Security Council outlined the National Strategy for Pandemic Influenza to…
Robert H Grubbs was awarded Nobel Prize in Chemistry
In 2005, Robert H. Grubbs, a professor at Caltech, shared the Nobel Prize for Chemistry with Yves Chauvin…